The Medical Industry Briefin g
The latest news, approvals and clinical trials you need to know about this month
The number of medical device types that undergo an EtO sterilisation process listed by Sterigenics, which could be affected by the closure of the company’s Willowbrook facility.
The number of biotech R&D companies in the UK has increased by 65% since 2016.
The global surgical robots market is expected to surpass $24bn by 2025; according to a new research report by Global Market Insights
The D2N2 Infrastructure and Investment Board will award up to £9.7m towards a new Nottingham medical technologies centre
The expected CAGR of the antimicrobial plastics market, which is forecast to reach $43.1bn by 2023
FDA clears Zimmer robot that combines brain, spine, knee functionality
Zimmer Biomet has received US FDA clearance for its Rosa One Spine system for robotically assisted surgery that works on the same platform as its brain and knee applications. The robotic, surgical navigation system is designed to aid surgeons in performing thoracolumbar minimally invasive and complex spine procedures.
Source: Med Tech Dive
FDA approves new device for treating patients with chronic heart failure
The Optimizer Smart System, created by Impulse Dynamics, monitors heart activity and delivers non-excitatory electrical signals to the right ventricle. It is claimed to provide patients with a higher quality of life and functional status, compared with those who only took medications.
Handheld CRISPR device to enable faster diagnosis of genetic disease
Called CRISPR-Chip, the device combines a deactivated clustered regularly interspaced short palindromic repeats Cas9 protein with electronic transistors to identify genetic mutations in DNA samples without the need for amplification or replication of the DNA segment using the polymerase chain reaction.
Source: Medical device network
Microgels let Medical Implants Fight off Bacteria
A research team at the US-based Stevens Institute of Technology has developed a microgel coating for implants to reduce post-surgical infection rates in patients. The new method is targeted and releases tiny quantities of antibiotics, which is contrary to the standard treatments that introduce antibiotics to the whole body.
Source: Stevens Institute of Technology
Embracing Emerging Technologies
The AWAK PD is a portable peritoneal dialysis device that allows dialysis patients to decide when and where they get their therapy delivered. It employs AWAK’s sorbent technology, which regenerates and reconstitutes used dialysis fluid into fresh fluid, and uses only two litres of PD fluid to deliver the daily therapy. This eliminates the need for a continuous water supply and large volumes of PD fluid used in current methods.
The ClearCell® FX1 System developed by Singapore-based startup Biolidics is a f fully automated device for cell retrieval in liquid biopsies. From a small blood sample, it can isolate and enrich varied populations of circulating tumour cells. Once the sample has passed through the ClearCell® FX1 System the enriched output is then ready for downstream analysis.
CroíValve has developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation. It can be delivered through a vein and into the heart, restoring the function of the tricuspid valve. The device seals the central gap between the native valve leaflets preventing regurgitation.
Sutrue has created automated medical stitching devices that are faster, more accurate and less traumatic to tissue than traditional techniques. The devices also protect the operator and ancillary staff from the sharp needle which in traditional suturing leads to needlestick injuries.
Share this article